Bimekizumab
For research use only. We do not sell to patients. Bimekizumab CAS No. : 1418205-77-2 Biological Activity:Bimekizumab (Anti-Human IL17A/IL-17F Recombinant Antibody) is a humanised monoclonal antibody, can selectively neutralises IL-17A and IL-17F. Both of them are pro-osteogenic with respect to human periosteum-derived cell (hPDC) differentiation. Thus Bimekizumab blocks the inflammation-driven osteogenic differentiation. Research Area:Inflammation/Immunology Targets:Interleukin […]